ViiV Healthcare’s Tivicay PD gains FDA approval for paediatric HIV therapy

The studies indicated that dolutegravir reached therapeutic levels in neonates and showed a safety profile similar to older patients. Credit: Gorodenkoff/Shutterstock.com.